Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (15) Pezzutto, Antonio Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Wollert-Wulf, Brigitte (3) (-) Janz, Martin Dr. (12) Bioinformatik der Genregulation (2) (-) Biologie maligner Lymphome (12) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Epigenetische Regulation und Chromatinstruktur (1) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Genomdiversifikation & Integrität (1) Immunregulation und Krebs (2) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Proteom Dynamik (19) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) Proteomics and Metabolomics (2) RNA Biologie und Posttranscriptionale Regulation (2) Systembiologie von Gen-regulatorischen Elementen (2) 1999 (1) 2000 (1) 2002 (1) 2003 (3) (-) 2004 (2) 2005 (2) (-) 2006 (4) (-) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) (-) 2012 (2) 2013 (2) 2014 (1) (-) 2015 (2) 2016 (1) 2017 (3) 2018 (1) 2019 (1) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) 12 Ergebnisse: Active Filter: Janz, Martin Dr.Biologie maligner Lymphome20042006200720122015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas 01. November 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou 01. Januar 2004 / Biochim Biophys Acta Gene Struct Expr Downregulation of genes involved in DNA repair and differential expression of transcription regulators and phosphatases precede IgM-induced apoptosis in the Burkitt's lymphoma cell line BL60-2 B. Schories M. Janz B. Doerken K. Bommert 19. April 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken 01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas
01. November 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou
01. Januar 2004 / Biochim Biophys Acta Gene Struct Expr Downregulation of genes involved in DNA repair and differential expression of transcription regulators and phosphatases precede IgM-induced apoptosis in the Burkitt's lymphoma cell line BL60-2 B. Schories M. Janz B. Doerken K. Bommert
19. April 2004 / J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken
01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken